Precision Oncology
The latest news on biomarker-guided cancer care.
Karolinska Institutet, Cellply Partner to Improve Knowledge of NK Cell Therapies in Multiple Myeloma
Researchers will use Cellply's VivaCyte platform to conduct single-cell analyses of NK cells and evaluate their ability to treat the bone marrow cancer.
Lantern Pharma Gains FDA Clearance to Test LP-184 in Non-Small Cell Lung Cancer Subset
The firm will test the drug with immune checkpoint inhibitors in NSCLC patients with low PD-L1 expression and KEAP1 and/or STK11 mutations.
Trump Signs Executive Order on Matching US Drug Costs to Lower Prices Abroad
In his first term, pharmaceutical companies took the "most favored nation" policy to court over the White House's effort to slash costs for patients.
Genomate Health Raises $2M, Enters US Market With Precision Oncology Clinical Decision Support Tool
The company plans to bring its genomics-based precision oncology drug selection platform to US healthcare systems.
Hoth Therapeutics Eyeing Human Trials for HT-KIT Antisense Therapy in Early 2026
After seeing promising results in preclinical studies, the firm hopes to begin Phase I trials shortly after getting IND clearance.
May 8, 2025
May 5, 2025